Itron’s (ITRI) “Buy” Rating Reaffirmed at Roth Mkm

Itron (NASDAQ:ITRI)‘s stock had its “buy” rating reaffirmed by Roth Mkm in a report issued on Tuesday, Benzinga reports. They presently have a $102.00 price target on the scientific and technical instruments company’s stock. Roth Mkm’s price target points to a potential upside of 8.03% from the stock’s current price.

A number of other research analysts also recently issued reports on ITRI. Raymond James downgraded shares of Itron from an “outperform” rating to a “market perform” rating in a research report on Thursday, January 4th. TheStreet raised Itron from a “c” rating to a “b-” rating in a research report on Monday, February 26th. Robert W. Baird increased their price objective on Itron from $108.00 to $115.00 and gave the company an “outperform” rating in a report on Wednesday, March 13th. Piper Sandler cut their price objective on Itron from $105.00 to $103.00 and set an “overweight” rating for the company in a report on Thursday, April 11th. Finally, TD Cowen raised their price target on Itron from $107.00 to $110.00 and gave the company an “outperform” rating in a report on Wednesday, March 13th. Three analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $97.60.

Itron Trading Down 0.4 %

Shares of ITRI stock opened at $94.42 on Tuesday. Itron has a 1 year low of $50.60 and a 1 year high of $96.73. The firm’s fifty day simple moving average is $88.66 and its 200 day simple moving average is $75.52. The firm has a market capitalization of $4.33 billion, a P/E ratio of 44.96, a price-to-earnings-growth ratio of 1.01 and a beta of 1.41. The company has a current ratio of 1.95, a quick ratio of 1.43 and a debt-to-equity ratio of 0.34.

Itron (NASDAQ:ITRI) last announced its quarterly earnings results on Monday, February 26th. The scientific and technical instruments company reported $1.23 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.75 by $0.48. Itron had a net margin of 4.46% and a return on equity of 12.27%. The firm had revenue of $577.17 million for the quarter, compared to analyst estimates of $569.90 million. During the same quarter in the previous year, the firm posted $0.71 EPS. The business’s revenue for the quarter was up 23.5% on a year-over-year basis. As a group, sell-side analysts predict that Itron will post 3.61 EPS for the current year.

Insider Buying and Selling at Itron

In other Itron news, CEO Thomas Deitrich sold 1,912 shares of Itron stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total value of $144,107.44. Following the transaction, the chief executive officer now directly owns 169,073 shares of the company’s stock, valued at approximately $12,743,032.01. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Thomas Deitrich sold 1,912 shares of Itron stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total transaction of $144,107.44. Following the sale, the chief executive officer now directly owns 169,073 shares in the company, valued at $12,743,032.01. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, SVP Donald L. Reeves III sold 383 shares of the business’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $75.37, for a total value of $28,866.71. Following the completion of the transaction, the senior vice president now owns 8,708 shares of the company’s stock, valued at approximately $656,321.96. The disclosure for this sale can be found here. Insiders have sold a total of 30,467 shares of company stock valued at $2,752,520 in the last 90 days. Corporate insiders own 1.45% of the company’s stock.

Hedge Funds Weigh In On Itron

A number of hedge funds have recently made changes to their positions in the business. CUSHING ASSET MANAGEMENT LP dba NXG INVESTMENT MANAGEMENT purchased a new stake in Itron during the first quarter valued at approximately $1,573,000. Assenagon Asset Management S.A. grew its stake in Itron by 32.2% in the first quarter. Assenagon Asset Management S.A. now owns 248,992 shares of the scientific and technical instruments company’s stock worth $23,037,000 after purchasing an additional 60,635 shares in the last quarter. AlphaMark Advisors LLC bought a new stake in Itron during the 1st quarter valued at $373,000. Oliver Luxxe Assets LLC acquired a new stake in shares of Itron in the 1st quarter worth $768,000. Finally, Contravisory Investment Management Inc. boosted its position in shares of Itron by 61.5% in the 1st quarter. Contravisory Investment Management Inc. now owns 344 shares of the scientific and technical instruments company’s stock worth $32,000 after purchasing an additional 131 shares in the last quarter. Institutional investors own 96.19% of the company’s stock.

Itron Company Profile

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.